| TRI
Sections |
 |
AHSR
PRESENTATIONS
To
download a presentation, right-click and select "Save Target As...".
Michael
T. French, Ph.D., Economic Research
Constance M. Weisner,
Dr.P.H, M.S.W., Treatment Services Research
Planning
Placement and Measuring Process: The ASAM Criteria and the Washington
Circle Performance Measures
Moderator: David
R. Gastfriend, M.D.
Deborah
Garnick, Sc.D. & Constance Horgan, Sc.D.
Treatment
Outcome and Quality Improvement
James R. McKay,
Ph.D., Selecting Continuing Care Models on the Basis of Initial Progress
in Treatment
Patricia A. Ebener
, Partnering to improve quality of care in addiction treatment
Grant R. Grissom,
Ph.D., Evidence-based Treatment and Quality Improvement: Results from
Integration of a NIDA-Sponsored ASI-based Automated Outcomes System into
Routine CD Treatment
David S. Festinger,
Ph.D., Matching Judicial Supervision to Client Risk Status in Drug
Courts
Housing, Employment,
Welfare Issues in Treatment
Stefan G. Kertesz,
MD MSc, Is addiction treatment enough? Long-term employment and housing
outcomes among treated homeless cocaine abusers
Kim Blanchard,
Ph.D., Twenty-Four Month Outcomes of a Public Health Approach for
Assisting Substance Abusing TANF Women in New Jersey
Kirk M. Broome,
Ph.D., Current Practices in Systems Integration among Outpatient Drug-Free
Treatment Providers
Co-Occurring
Substance Use & Mental Health Issues in Treatment
Mark Edlund, Ph.D.,
Substance abuse treatment and mental health care use by adults with
co-occurring disorders
Mark P. McGovern,
Ph.D., Development and application of an index of dual diagnosis capability
in addiction treatment programs
Stacy A Sterling
MSW, MPH, Chemical dependency and psychiatric services for adolescents
in private managed care: Implications for outcomes
Laurel Mangrum,
Ph.D. & Richard Spence, Ph.D., A Comparison of Characteristics and
Outcomes of clients with Co-occurring Psychological and Substance Abuse
Treatment Population
Health Services
Research in NIDA’s Clinical Trials Network
Dennis McCarty,
Ph.D., Counselors Working in Treatment Units Participating in The
National Drug Abuse Treatment Clinical Trials Network
Robert F. Forman,
Ph.D., Patient Feedback: A Performance Feedback System for Improving
Engagement in Outpatient Addiction Treatment
Joseph
Guydish, Ph.D., Adoption of Innovative Practices in the Context of
Clinical Trials
Kathryn Magruder,
Ph.D., M.P.H., Program influences on recruitment and retention of
minority participants in addictions treatment research
Beverly Pringle,
Ph.D., Future Directions and Funding Opportunities at the National
Institute on Drug Abuse
Organizational
Issues in Substance Abuse Treatment
Laurie Russell
MS, RN & Kenneth Stoller M.D., Operationalizing integrated managed
care for a Medicaid population with substance abuse and high medical expenses
Lori Ducharme,
Ph.D., Comprehensive treatment services: Comparing the public and
private sectors
Constance M. Horgan,
Sc.D., Getting Into and Staying in Treatment: Changes in How Health
Plans Provide Addiction Services
Bret Fuller, Ph.D.,
Elimination of Methadone Benefits in the Oregon Health Plan; Patient Impacts
Financing
and Cost of Substance Abuse Treatment
Gary A.
Zarkin & Laura J. Dunlap, Benefits and Costs of Methadone Treatment:
Results from a Lifetime Simulation Model
Dennis Deck, Ph.D.,
Impact of Financing on Retention in Publicly Funded Methadone Treatment
Kathryn McCollister,
Ph.D., Re-estimating the Cost of Crime to Society
Carmen L. Masson,
Ph.D., Impact of drug treatment linkage interventions on health service
use and costs: 6-month outcomes from a randomized controlled trial
Financing
and Costs II
Elizabeth Agius,
Impact of turnover on organizational climate of substance abuse treatment
clinics
Victoria L. Brown,
Ph.D., Employment: Tertiary Drug Use Prevention for Welfare Recipients?
Alex J. Cowell,
Examining Variation in Treatment Costs: A Cost Function for Outpatient
Methadone Treatment Programs
Keynote Address
Nora D. Volkow,
M.D.
|